ArticleTherapeutic advances in neurological disorders2025

Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.

Afsaneh Shirani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.